Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Kalra

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Breast Cancer Research : BCR|May 5, 2009
QLT0267, a small molecule inhibitor targeting integrin-linked kinase (ILK), and docetaxel can combine to produce synergistic interactions linked to enhanced cytotoxicity, reductions in P-AKT levels, altered F-actin architecture and improved treatment outcomes in an orthotopic breast cancer modelJessica Kalra, Corinna Warburton, Karen Fang, et al.
The Journal of Biological Chemistry|July 5, 2014
5'-AMP-activated protein kinase (AMPK) supports the growth of aggressive experimental human breast cancer tumorsKeith R Laderoute, Joy M Calaoagan, Wan-Ru Chao, et al.
Molecular Cancer Therapeutics|January 19, 2008
Suppression of VEGF secretion and changes in glioblastoma multiforme microenvironment by inhibition of integrin-linked kinase (ILK)Lincoln A Edwards, Janet Woo, Lynsey A Huxham, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Breast Cancer Research : BCR|May 5, 2009
QLT0267, a small molecule inhibitor targeting integrin-linked kinase (ILK), and docetaxel can combine to produce synergistic interactions linked to enhanced cytotoxicity, reductions in P-AKT levels, altered F-actin architecture and improved treatment outcomes in an orthotopic breast cancer modelJessica Kalra, Corinna Warburton, Karen Fang, et al.
The Journal of Biological Chemistry|July 5, 2014
5'-AMP-activated protein kinase (AMPK) supports the growth of aggressive experimental human breast cancer tumorsKeith R Laderoute, Joy M Calaoagan, Wan-Ru Chao, et al.
Molecular Cancer Therapeutics|January 19, 2008
Suppression of VEGF secretion and changes in glioblastoma multiforme microenvironment by inhibition of integrin-linked kinase (ILK)Lincoln A Edwards, Janet Woo, Lynsey A Huxham, et al.
Pageof 2